Trial Profile
An Open Label, Non Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non- Breastfeeding Mothers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Deep vein thrombosis
- Focus Pharmacokinetics
- Acronyms DALMATION
- 19 Feb 2016 Status changed from not yet recruiting to recruiting, according to United Kingdom Clinical Research Network record.
- 16 Dec 2015 New trial record